Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phas...

por Griese, Matthias, Costa, Stefano, Linnemann, Rachel W., Mall, Marcus A., McKone, Edward F., Polineni, Deepika, Quon, Bradley S., Ringshausen, Felix C., Taylor-Cousar, Jennifer L., Withers, Nicholas J., Moskowitz, Samuel M., Daines, Cori L.
Publicado 2021